In the glioblastoma cell lines autophagy was induced following cannabinoid therapy (acting on cannabinoid receptors), and in crizotinib-resistant NSCLC cells, high doses (1 to 8 μM) of crizotinib were used in cells harboring a loss of EML4-ALK. Here, EML4 is linked to non-small cell lung carcinoma.